UPDATE 1-AstraZeneca's immunotherapy drug wins key lung cancer approval
February 17, 2018 at 05:07 AM EST
* Rival BMS, Merck, Roche drugs approved for later disease (Adds details on competition, size of market opportunity)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|